@dachopper excellent find! while it looks like a hopeful approach it also appears to be in very early investigational phase with mostly academic focus on treatment of MS. could be worthwhile to throw at ARDS in a prelim small study. and of course there is the great benefit of having MSC-like effects without the heavy MSC manufacturing and distribution burdens. thanks for posting.
Cell Therapy News/Articles, page-2200
-
- There are more pages in this discussion • 16,207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |